Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

GRI Bio Expands Intellectual Property Protection For Proprietary Natural Killer T Cell Modulators With Issuance Of Korea Patent

Author: Benzinga Newsdesk | April 16, 2024 08:35am

Ongoing efforts to build a robust global patent estate for a growing pipeline targeting high-value indications in need of innovation

Continued advancement of an innovative pipeline of NKT cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases

Posted In: GRI